Adar Poonawalla, the CEO of Serum Institute of India and the manufacturer of Covishield has announced a reduction of 25 percent in the price of the vaccine.
Terming it as a philanthropic move, Poonawalla informed that the price of Covishield has been slashed to Rs 300/ dose for the states effective immediately, as per a CNBC TV18 report. He says the move was in the interest of states to help save funds.
#CNBCTV18Exclusive: Adar Poonawalla says, “We have taken a philanthropic decision to reduce the price of #Covishield for states by 25 percent to Rs 300/ dose effective immediately. Doing so in the interest of saving states funds”@shereenbhan pic.twitter.com/uhXCPv7Uii
— CNBC-TV18 (@CNBCTV18Live) April 28, 2021
In a tweet, Poonawalla further stated that the price reduction will enable state governments to save crores and will also encourage more vaccinations, thereby saving countless lives.
The Serum Institute of India had earlier announced the prices of its Covid-19 vaccine Covishield for State governments and private hospitals at Rs 400 per dose, and Rs 600 per dose respectively.
A statement was released by the Serum Institute of India in which it made the announcement of providing its vaccines to the state governments and private hospitals in the wake of the broad guidelines issued by the central government for the procurement of vaccines.
IMPORTANT ANNOUNCEMENT pic.twitter.com/bTsMs8AKth
— SerumInstituteIndia (@SerumInstIndia) April 21, 2021
Multiple states have already placed orders in bulk with the SII for procurement of the Covishield for Phase 03 of the vaccination drive which opens on May 01 for beneficiaries between 18 to 45 years.
